A diagnostic biomarker for prodromal dementia with Lewy bodies

Takeaway

  • The cerebrospinal fluid (CSF) α-synuclein (α-syn) real-time quaking-induced conversion (RT-QuIC) assay was a robust biomarker for prodromal dementia with Lewy bodies (DLB).

Why this matters

  • The RT-QulC assay is a highly sensitive assay for prion detection that has been shown to accurately detect misfolded α-syn in the CSF of patients with DLB or Parkinson’s disease.

  • The diagnostic value of this assay in patients with mild cognitive impairment (MCI), a common manifestation of prodromal DLB, has not been previously studied.